London, 03 September 2015 – Technavio, a tech-focused research firm, has published a new report on the global hospital acquired disease testing market, which is expected to grow at a CAGR of more than 19% from 2015-2019.
The latest report by Technavio analyses the rise in morbidity and mortality from hospital acquired infectious diseases, which had significant economic consequences for healthcare systems. Some of the reasons for the emergence of infectious diseases are global climate change, increase in the use of invasive equipment in hospitals, the aging population, and population explosion.
“There has been a dramatic increase in the number of patients who have succumbed to infectious respiratory, gastrointestinal, and hospital acquired infections. Hence, early diagnosis and regular monitoring of patients with these diseases is essential to identify, treat, and control their spread,” says Faisal Ghaus, Vice President of Technavio.
The new Technavio report also highlights the mounting pressure on hospitals and other healthcare entities to reduce the healthcare expenditure without compromising the quality of treatment and increase better patient outcomes.
“There is an increasing focus towards early diagnosis and preventive medicine to reduce the length of stay in the hospital and reduce treatment costs,” adds Ghaus.
https://www.technavio.com/%3Cp%3E%3Cstrong%3E%3Ca%20href%3D%22http%3A//ww…
